Pharmacokinetics during pregnancy: Evidence-based maternal dose formulation

Obstetrics and Gynecology

Volumn 93, Issue 5 SUPPL., 1999, Pages 858-868

  Little, Bertis B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; AZLOCILLIN; CARBAMAZEPINE; CARDIOVASCULAR AGENT; CEFAZOLIN; CEFRADINE; CEFUROXIME; INDOMETACIN; LABETALOL; MEPTAZINOL; METOPROLOL; MORPHINE; PARACETAMOL; PETHIDINE; PHENOBARBITAL; PHENYTOIN; PIPERACILLIN; SALICYLATE SODIUM; UNINDEXED DRUG; UTERUS SPASMOLYTIC AGENT; VALPROIC ACID; XANTHINE DERIVATIVE;

AREA UNDER THE CURVE; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; PREGNANCY; PRIORITY JOURNAL; REVIEW;

ANALGESICS; ANTICONVULSANTS; CARDIOVASCULAR AGENTS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PREGNANCY; TOCOLYTIC AGENTS; XANTHINES;

EID: 0032922072     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00444-X     Document Type: Review

References (87)

1. Poe C.F., Suchy J.F., Witt N.F. Toxicity of strychnine for male and female rats of different ages. J Pharmacol Exp Ther. 58:1936;239-242.
2. Holck H.G.O. Studies on sex variation to picrotoxin in the albino rat. J Am Pharm Assoc. 38:1937;604-610.
3. Holck H.G.O., Kanan M.A., Mills L.M., Smith E.L. Studies upon the sex difference in rats' intolerance to certain barbiturates and nicotine. J Pharmacol Exp Ther. 60:1949;323-346.
4. Pritchard J.A. Plasma cholinesterase activity in normal pregnancy and in eclamptogenic toxemias. Am J Obstet Gynecol. 70:1955;1083-1086.
5. Murphy S.D., DuBois K.P. Influence of various factors on the enzymatic conversion of organic thiophosphates to anticholinesterase agents. J Pharmacol Exp Ther. 124:1958;194-202.
6. Shnider S.M. Serum cholinesterase activity during pregnancy, labor and puerperium. Anesthesiology. 26:1965;335-339.
7. Crawford J.S., Rudofsky S. Some alterations in the pattern of drug metabolism associated with pregnancy, oral contraceptives, and the newly-born. Br J Anaesth. 38:1966;446-454.
8. Davis M., Simmons C.J., Dordoni B., Maxwell J.D. Induction of hepatic enzymes during normal human pregnancy. J Obstet Gynaecol Br Commonw. 80:1973;690-694.
9. Lander C.M., Edwards V.E., Eadie M.J., Tyrer J.H. Plasma anticonvulsant concentrations during pregnancy. Neurology. 27:1977;128-131.
10. Berg M.J. Status of research on gender differences. J Am Pharm Assoc. 37:1997;43-56.
11. Harris R.Z., Benet L.Z., Schwartz J.B. Gender effects in pharmacokinetics and pharmacodynamics. Drugs. 50:1995;222-239.
12. Mattison D.R., Malek A., Cistola C. Physiologic adaptations to pregnancy Impact on pharmacokinetics . Yaffe S.J., Aranda J.V. Pediatric pharmacology Therapeutic principles in practice . 1992;81-96 WB Saunders, Philadelphia.
13. Amon I., Hüller H. Dose-response relationship as a basis for choice of drugs in pregnancy and for dosage calculation. Kuemmerle H.P., Brendel K. Clinical pharmacology in pregnancy Fundamentals and rational pharmacotherapy . 1984;64-73 Thieme-Stratton, New York.
14. Hunt J.N., Murray F.A. Gastric function in pregnancy. Br J Obstet Gynaecol. 65:1958;78-83.
15. Perry E., Shields R., Turnbull A.C. Transit time in the small intestine in pregnancy. Br J Obstet Gynaecol. 77:1970;900-901.
16. Mattison D.R. Physiologic variations in pharmacokinetics during pregnancy. Fabro S., Scialli A. Drug and chemical action in pregnancy Pharmacologic and toxicologic principles . 1986;37-102 Marcel Dekker, New York.
17. Cunningham F.G., MacDonald P., Gant N.F., Leveno K.J., Gilstrap L.C., Hankins G.D.V., et al. Williams obstetrics. 1997;Appleton and Lange, Stamford, Connecticut.
18. Perucca E., Crema A. Plasma protein binding of drugs in pregnancy. Clin Pharmacokinet. 7:1982;336-352.
19. Amon I., Hüller H. Drug metabolism in pregnant women. Kuemmerle H.P., Brendel K. Clinical pharmacology in pregnancy Fundamentals and rational pharmacotherapy . 1984;74-86 Thieme-Stratton, New York.
20. Vesell E.S. Clinical pharmacokinetics. Yaffe S.J., Aranda J.V. Pediatric pharmacology Therapeutic principles in practice . 1997;29-44 WB Saunders, Philadelphia.
21. Wood M., Wood A.J.J. Changes in plasma drug binding and alpha-1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther. 29:1981;522-526.
22. Dunlop W. Serial changes in renal haemodynamics during pregnancy. Br J Obstet Gynaecol. 8:1981;1-9.
23. Food and Drug Administration. Investigational new drug applications; proposed amendment to clinical hold regulations for products intended for life-threatening diseases. Federal Register. 62:1997;49946-49954.
24. Miners J.O., Robson R.A., Birkett D.J. Paracetamol metabolism in pregnancy. Br J Clin Pharmacol. 22:1986;359-362.
25. Rayburn W., Shukla U., Stetson P., Piehl E. Acetaminophen pharmacokinetics Comparison between pregnant and non-pregnant women . Am J Obstet Gynecol. 155:1986;1353-1356.
26. Kuhnert B.R., Kuhnert P.M., Prochaska A.L., Sokol R.J. Meperidine disposition in mother, neonate, and nonpregnant females. Clin Pharmacol Ther. 27:1980;486-491.
27. Murray G.R., Evans D., Lind T., Franklin R.A., Graham D.F. The disposition of meptazinol after single and multiple intravenous administration to pregnant and non-pregnant women. Eur J Clin Pharmacol. 36:1989;273-277.
28. Gerdin E., Salmonson T., Lindberg B., Rane A. Maternal kinetics of morphine during labour. J Perinat Med. 18:1990;479-487.
29. Traeger A., von Noschel H., Zaumseil J. Zur Pharmakokinetik von Indomethazin bei Schwangeren, Kreibenden und deren Neugeborenen. Zentralbl Gynakol. 95:1973;635-641.
30. Noschel H., Bonow A., Moller R., Estel C., Muller B. Plazentapassage von natriumsalizylat. Zentralbl Gynakol. 94:1972;437-442.
31. Flores-Mercado F., Garcia-Mercado J.L., Estopier-Jauregui C., Galindo-Hernandez E., Diaz-Gonzalez C. Clinical pharmacology of amikacin sulphate Blood, urinary and tissue concentrations in the terminal stage of pregnancy . J Int Med Res. 5:1977;292-294.
32. Assael B.F., Como M.L., Miraglia M., Pardi G., Sereni F. Ampicillin kinetics in pregnancy. Br J Clin Pharmacol. 8:1979;286-288.
33. Philipson A., Stiernstedt G., Ehrnebo M. Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women. Clin Pharmacokinet. 12:1987;136-144.
34. Voigt R., Schroder S., Meinhold P., Zenner I., Noschel H. Klinische untersuchungen zum Einflub von schwangerschaft und geburt auf die pharmakokinetik von ampizillin. Zentralbl Gynakol. 100:1978;701-705.
35. Voigt R., Schroder S., Peiker G. Pharmacokinetic studies of azlocillin and piperacillin during late pregnancy. Chemotherapy. 31:1985;417-424.
36. Kafetzis D.A., Brater D.C., Fanourgakis J.E. Materno-fetal transfer of azlocillin. J Antimicrob Chemother. 12:1983;157-162.
37. Philipson A. Pharmacokinetics of antibiotics in pregnancy and labour. Clin Pharmacokinet. 4:1979;297-299.
38. Philipson A., Stiernstedt G. Pharmacokinetics of cefuroxime in pregnancy. Am J Obstet Gynecol. 142:1982;823-828.
39. Dam J., Christiansen J., Munck O., Mygind K.I. Antiepileptic drugs Metabolism in pregnancy . Clin Pharmacokinet. 4:1979;53-62.
40. Bardy A.H., Teramo K., Hiilesmaa V.K. Apparent plasma clearances of phenytoin, phenobarbitone, primidone, and carbamazepine during pregnancy Results of the prospective Helsinki study . Janz D., Dam M., Richens A., Bossi L., Helge M., Schmidt D. Epilepsy, pregnancy, and the child. 1982;141-145 Raven Press, New York.
41. Bologa M., Tang B., Klein J., Tesoro A., Koren G. Pregnancy-induced changes in drug metabolism in epileptic women. J Pharmacol Exp Ther. 267:1991;735-740.
42. Froescher W., Niesen M., Altman D., Eichelbaum M., Gugler R., Hoffman F., et al. Antiepileptika-Therapie wahrend der Schwangerschaft und Geburt. Remschmidt H. Epilepsie 1980. 1981;152-163 Georg Thieme, Stuttgart, Germany.
43. Battino D., Binelli S., Bossi L., Canger R., Croci D., Cusi C., et al. Plasma concentrations of carbamazepine and carbamazepine 10, 11-epoxide during pregnancy and after delivery. Clin Pharmacokinet. 10:1985;279-284.
44. Battino D., Avanzini G., Bossi L., Canger R., Como M.L., Croci D., et al. Monitoring of antiepileptic drugs plasma levels during pregnancy and puerperium. Janz D., Dam M., Richens A., Bossi L., Helge M., Schmidt D. Epilepsy, pregnancy, and the child. 1982;147-154 Raven Press, New York.
45. Omtzigt J.G.C., Los F.J., Meijer J.W.A., Lindhout D. The 10,11-epoxide-10, 11-diol pathway of carbamazepine in early pregnancy in maternal serum, urine, and amniotic fluid Effect of dose, comedication, and relation to outcome of pregnancy . Ther Drug Monit. 15:1993;1-10.
46. Yerby M.S., Friel P.N., Miller D.Q. Carbamazepine protein binding and disposition in pregnancy. Ther Drug Monit. 7:1985;269-273.
47. Lander C.M., Smith M.T., Chalk J.B., deWytt C., Symoniw P., Livingstone I., et al. Bioavailability and pharmacokinetics of phenytoin during pregnancy. Eur J Clin Pharmacol. 27:1984;105-110.
48. Dansky L., Andermann E., Sherwin A.L., Andermann F. Plasma levels of phenytoin during pregnancy and the puerperium. Janz D., Dam M., Richens A., Bossi L., Helge M., Schmidt D. Epilepsy, pregnancy, and the child. 1982;155-162 Raven Press, New York.
49. Chen S.S., Perucca E., Lee J.J., Richens A. Serum protein binding and free concentration of phenytoin and phenobarbitone in pregnancy. Br J Clin Pharmacol. 13:1982;547-552.
50. Ruprah M., Perucca E., Richens A. Serum protein binding of phenytoin in women Effect of pregnancy and oral contraceptives . Janz D., Dam M., Richens A., Bossi L., Helge M., Schmidt D. Epilepsy, pregnancy, and the child. 1982;115-120 Raven Press, New York.
51. Battino D., Binelli S., Bossi L., Como M.L., Croci D., Cusi C., et al. Changes in primidone/phenobarbitone ratio during pregnancy and the puerperium. Clin Pharmacokinet. 9:1984;252-260.
52. Nau H., Schmidt D., Beck-Mannagett G., Rating D., Koch S., Helge H. Pharmacokinetics of primidone and metabolites during human pregnancy. Janz D., Dam M., Richens A., Bossi L., Helge M., Schmidt D. Epilepsy, pregnancy, and the child. 1982;121-130 Raven Press, New York.
53. Nau H., Wittfoht W., Rationg D., Jakobs C., Schafer H., Helge H. Pharmacokinetics of valproic acid and its metabolites in a pregnant patient Stable isotope methodology . Janz D., Dam M., Richens A., Bossi L., Helge M., Schmidt D. Epilepsy, pregnancy, and the child. 1982;147-154 Raven Press, New York.
54. Nau H., Kuhnz W., Egger H.-J., Rating D., Helge H. Anticonvulsants during pregnancy and lactation Transplacental, maternal and neonatal pharmacokinetics . Clin Pharmacokinet. 7:1982;508-543.
55. Otani K. Risk factors for the increased seizure frequency during pregnancy and puerperium. Folia Psychiatr Neurol Jpn. 39:1985;33-41.
56. Rogers R.C., Sibai B.M., Whybrew W.D. Labetalol pharmacokinetics of pregnancy-induced hypertension. Am J Obstet Gynecol. 162:1990;362-366.
57. Rubin P.C., Butters L., Kelman A.W., Fitzsimons C., Reid J.L. Labetalol disposition and concentration-effect relationships during pregnancy. J Clin Pharmacol. 15:1983;465-470.
58. Saotome T., Minoura S., Terashi K., Sato T., Echizen H., Ishizaki T. Labetalol in hypertension during the third trimester of pregnancy Its antihypertensive effect and pharmacokinetic-dynamic analysis . J Clin Pharmacol. 33:1993;979-988.
59. Hogstedt S., Lindberg B., Peng D.R., Regardh C.-G., Rane A. Pregnancy-induced increase in metoprolol metabolism. Clin Pharmacol Ther. 37:1985;688-692.
60. O'Hare M.F., Kinney C.D., Murnaghan G.A., McDevitt D.G. Pharmacokinetics of propranolol during pregnancy. Eur J Clin Pharmacol. 27:1984;583-587.
61. O'Hare M.F., Leahey W., Murnaghan G.A., McDevitt D.G. Pharmacokinetics of sotalol during pregnancy. Eur J Clin Pharmacol. 24:1983;521-524.
62. Luxford A.M.E., Kellaway G.S.M. Pharmacokinetics of digoxin in pregnancy. Eur J Clin Pharmacol. 25:1983;117-121.
63. Rogers M.C., Willerson J.T., Goldblatt A., Smith T.W. Serum digoxin concentrations in the human fetus, neonate and infant. N Engl J Med. 287:1972;1010-1013.
64. Gardner M.J., Schatz M., Cousins L., Zeiger R., Middleton E., Jusko W.J. Longitudinal effects of pregnancy on the pharmacokinetics of theophylline. Eur J Clin Pharmacol. 31:1987;289-295.
65. Frederiksen M.C., Ruo T.I., Chow M.J., Atkinson A.J. Theophylline pharmacokinetics in pregnancy. Clin Pharmacol Ther. 40:1986;321-328.
66. Carter B.L., Driscoll C.E., Smith G.D. Theophylline clearance during pregnancy. Obstet Gynecol. 68:1986;555-559.
67. Aldridge A., Bailey J., Neims A.H. The disposition of caffeine during and after pregnancy. Semin Perinatol. 5:1981;310-314.
68. Knutti R., Rothweiler H., Schlatter C.H. Effect of pregnancy on the pharmacokinetics of caffeine. Eur J Clin Pharmacol. 21:1981;121-126.
69. Mandach U., vonBoni R., Danko J., Huch R., Huch A. Pharmacokinetics of fenoterol in pregnant women. Arzneim Forsch. 45:1995;186-189.
70. Van Lierde M., Desager J.P., Harvengt C., Thomas K. Ritodrine serum levels Influence of dose and route of administration . Int J Clin Pharmacol Ther Toxicol. 22:1984;382-385.
71. Caritis S.N., Venkataramanan R., Cotroneo M., Chiao J.-P. Pharmacokinetics of orally administered ritodrine. Am J Obstet Gynecol. 161:1989;32-35.
72. Hutchings M.J., Paull J.D., Wilson-Evered E., Morgan D.J. Pharmacokinetics and metabolism of salbutamol in premature labour. Br J Clin Pharmacol. 24:1987;69-75.
73. Berg G., Lindberg C., Ryden G. Terbutaline in the treatment of preterm labour. Eur J Respir Dis. 65:1984;219-230.
74. Rey E., d'Athis P.H., Giraux P., de Lautre D., Turquais J.M., Chavine J., et al. Pharmacokinetics of clorazepate in pregnant and non-pregnant women. Eur J Clin Pharmacol. 15:1979;175-180.
75. Tsuei S.E., Petersen M.C., Ashley J.J., McBride W.G., Moore R.G. Disposition of synthetic glucocorticoids. II. Dexamethasone in parturient women. Clin Pharmacol Ther. 28:1980;88-98.
76. Elliott C.L., Read G.F., Wallace E.M. The pharmacokinetics of oral and intramuscular administration of dexamethasone in late pregnancy. Acta Obstet Gynecol Scand. 75:1996;213-216.
77. Moore R.G., McBride W.G. The disposition kinetics of diazepam in pregnant women at parturition. Eur J Clin Pharmacol. 13:1978;275-284.
78. Riva E., Farina P., Tognoni G., Bottino S., Orrico C., Pardi G. Pharmacokinetics of furosemide in gestosis of pregnancy. Eur J Clin Pharmacol. 14:1978;361-366.
79. Brancazio L.R., Roperti K.A., Stierer R., Laifer S.A. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol. 173:1995;1240-1245.
80. Skellern G.G., Knight B.I., Low C.K.L., Alexander W.D. Pharmacokinetics of methimazole in pregnant patients after oral administration of carbimazole. Br J Clin Pharmacol. 9:1980;145-147.
81. Wisner K.L., Perel J.M., Wheeler S.B. Tricyclic dose requirements across pregnancy. Am J Psychiatry. 150:1993;1541-1542.
82. Tomson G., Lunell N.-O., Sundwall A., Rane A. Placental passage of oxazepam and its metabolism in mother and newborn. Clin Pharmacol Ther. 25:1979;74-81.
83. Dawood M.Y., Ylikorkala O., Fuchs F. Plasma oxytocin levels and disappearance rate after buccal Pitocin. Am J Obstet Gynecol. 138:1980;20-24.
84. Duvaldstein P., Demetriou M., Henzel D., Desmots J.M. The placental transfer of pancuronium and its pharmacokinetics in cesarean section. Acta Anaesthesiol Scand. 22:1978;327-333.
85. Philipson A. Plasma levels of ampicillin in pregnant women following administration of ampicillin and pivampicillin. Am J Obstet Gynecol. 130:1978;674-683.
86. Cummings A.J. A survey of pharmacokinetic data from pregnant women. Clin Pharmacokinet. 8:1983;344-354.
87. Reynolds F. Pharmacokinetics. Hytten F., Chamberlain G. Clinical physiology in obstetrics. 1991;224-241 Blackwell Scientific Publications, London.